Silica-coated papillomavirus-based nanoparticles: a shielded scaffold for HIV-1 vaccines

Wang Y, Kostka-Wirtz K, Bartelsen N, Loza K, Weingärtner C, Arnold P, Damm D, Überla K, Epple M, Temchura V (2026)


Publication Type: Journal article

Publication year: 2026

Journal

DOI: 10.1039/d5bm01792k

Abstract

The development of a safe, effective, and accessible human immunodeficiency virus 1 (HIV-1) vaccine remains a global priority, and nanoparticles (NPs) have emerged as a promising platform for vaccine delivery. However, the efficacy of protein-based NP vaccines is often limited by pre-existing immunity against scaffold components. In this study, we developed a novel HIV-1 vaccine platform by converting self-assembling human papillomavirus (HPV) L1 virus-like particles (VLPs) into immune-stealth biomaterials for focused antigen delivery. Encapsulation of VLPs within a silica shell provided both immune shielding and a surface for site-specific antigen conjugation. The resulting L1-SiO2 NPs were covalently functionalized with HIV-1 Env trimers (L1-SiO2-Env) and characterized for their physicochemical properties and immunogenicity. In vivo, the silica coating effectively masked L1-specific B cell epitopes, reduced anti-scaffold IgG responses and enhanced Env-specific antibody production in mice pre-immunized against HPV. This synthetic strategy offers a versatile platform for overcoming scaffold-directed immunity in nanoparticle vaccines.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Wang, Y., Kostka-Wirtz, K., Bartelsen, N., Loza, K., Weingärtner, C., Arnold, P.,... Temchura, V. (2026). Silica-coated papillomavirus-based nanoparticles: a shielded scaffold for HIV-1 vaccines. Biomaterials Science. https://doi.org/10.1039/d5bm01792k

MLA:

Wang, Yu, et al. "Silica-coated papillomavirus-based nanoparticles: a shielded scaffold for HIV-1 vaccines." Biomaterials Science (2026).

BibTeX: Download